CalciMedica NASDAQ: CALC www.calcimedica.com
2 known investors
CalciMedica is a clinical-stage biopharmaceutical company developing CRAC (calcium release-activated calcium) channel inhibition therapies for serious acute and chronic inflammatory, immunologic, and cardiopulmonary diseases. Its drug candidates target conditions such as acute pancreatitis, acute kidney injury, and pulmonary arterial hypertension.
Founders & leadership
KA
Kenneth A. StaudermanCo-founder
GV
Gonul VelicelebiCo-founder
SB
Stephen BardinChief Financial Officer
SH
Sudarshan HebbarChief Medical Officer
AC
Andrew CunninghamExecutive
Board
EW
Eric W. RobertsChairman of the Board
Investors Β· 2
Frequently asked questions
- What does CalciMedica NASDAQ: CALC www.calcimedica.com do?
- CalciMedica is a clinical-stage biopharmaceutical company developing CRAC (calcium release-activated calcium) channel inhibition therapies for serious acute and chronic inflammatory, immunologic, and cardiopulmonary diseases. Its drug candidates target conditions such as acute pancreatitis, acute kidney injury, and pulmonary arterial hypertension.
- Who founded CalciMedica NASDAQ: CALC www.calcimedica.com?
- CalciMedica NASDAQ: CALC www.calcimedica.com was founded by Kenneth A. Stauderman, Gonul Velicelebi.
- Who are CalciMedica NASDAQ: CALC www.calcimedica.com's investors?
- CalciMedica NASDAQ: CALC www.calcimedica.com's investors include Aisling Capital, Sanderling Ventures.